102 related articles for article (PubMed ID: 2475104)
1. Cleavage of a 100 kDa membrane protein (aggregin) during thrombin-induced platelet aggregation is mediated by the high affinity thrombin receptors.
Puri RN; Zhou FX; Colman RF; Colman RW
Biochem Biophys Res Commun; 1989 Aug; 162(3):1017-24. PubMed ID: 2475104
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
[TBL] [Abstract][Full Text] [Related]
3. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
[TBL] [Abstract][Full Text] [Related]
4. Plasmin-induced platelet aggregation is accompanied by cleavage of aggregin and indirectly mediated by calpain.
Puri RN; Zhou FX; Colman RF; Colman RW
Am J Physiol; 1990 Dec; 259(6 Pt 1):C862-8. PubMed ID: 2148055
[TBL] [Abstract][Full Text] [Related]
5. Activation of platelets by alpha-thrombin is a receptor-mediated event. D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone-thrombin, but not N alpha-tosyl-L-lysine chloromethyl ketone-thrombin, binds to the high affinity thrombin receptor.
Harmon JT; Jamieson GA
J Biol Chem; 1986 Dec; 261(34):15928-33. PubMed ID: 3023333
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
Puri RN; Colman RF; Colman RW
Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
[TBL] [Abstract][Full Text] [Related]
7. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
[TBL] [Abstract][Full Text] [Related]
8. Aggregin: a platelet ADP receptor that mediates activation.
Colman RW
FASEB J; 1990 Mar; 4(5):1425-35. PubMed ID: 2407587
[TBL] [Abstract][Full Text] [Related]
9. PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change.
Greco NJ; Tenner TE; Tandon NN; Jamieson GA
Blood; 1990 May; 75(10):1989-90. PubMed ID: 2337670
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
Puri RN; Colman RW
J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation by thrombin in the absence of the high-affinity thrombin receptor.
Harmon JT; Jamieson GA
Biochemistry; 1988 Mar; 27(6):2151-7. PubMed ID: 2837284
[TBL] [Abstract][Full Text] [Related]
12. Platelet activation by alpha-thrombin is a receptor-mediated event.
Harmon JT; Jamieson GA
Ann N Y Acad Sci; 1986; 485():387-95. PubMed ID: 3032051
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogen.
Puri RN; Gustafson EJ; Zhou FX; Bradford H; Colman RF; Colman RW
Trans Assoc Am Physicians; 1987; 100():232-40. PubMed ID: 3455067
[TBL] [Abstract][Full Text] [Related]
14. Platelet receptors.
Colman RW
Hematol Oncol Clin North Am; 1990 Feb; 4(1):27-42. PubMed ID: 2155904
[TBL] [Abstract][Full Text] [Related]
15. Reocclusion after thrombolytic therapy: strategies for inhibiting thrombin-induced platelet aggregation.
Puri RN; Colman RW
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):465-78. PubMed ID: 8329574
[TBL] [Abstract][Full Text] [Related]
16. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor.
Puri RN; Colman RW
Anal Biochem; 1996 Sep; 240(2):251-61. PubMed ID: 8811919
[TBL] [Abstract][Full Text] [Related]
17. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo.
Nierodzik ML; Plotkin A; Kajumo F; Karpatkin S
J Clin Invest; 1991 Jan; 87(1):229-36. PubMed ID: 1845869
[TBL] [Abstract][Full Text] [Related]
18. Distinction between glycoprotein IIIa and the 100-kDa membrane protein (aggregin) mediating ADP-induced platelet activation.
Colman RW; Figures WR; Wu QX; Chung SY; Morinelli TA; Tuszynski GP; Colman RF; Niewiarowski S
Arch Biochem Biophys; 1988 Apr; 262(1):298-306. PubMed ID: 3281588
[TBL] [Abstract][Full Text] [Related]
19. Receptors that activate platelets.
Colman RW
Proc Soc Exp Biol Med; 1991 Jul; 197(3):242-8. PubMed ID: 1648741
[TBL] [Abstract][Full Text] [Related]
20. Dual regulation of cyclic AMP formation by thrombin in HEL cells, a leukaemic cell line with megakaryocytic properties.
Brass LF; Woolkalis MJ
Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):73-80. PubMed ID: 1310010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
